Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Cook

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Blood Reviews|April 30, 2013
Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM)Sylvia Feyler, Peter J Selby, Gordon Cook
British Journal of Haematology|November 15, 2020
Evolution or revolution in multiple myeloma therapy and the role of the UKGordon Cook, Curly T C M Morris
Palliative & Supportive Care|September 26, 2025
Advance care planning in haematological malignancies: A qualitative exploratory analysis of the facilitators and barriers to implementing advance care planning in practiceJenna Tate, Christopher Parrish, Anjum Khan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 12, 2016
Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in MyelomaBernard Maybury, Gordon Cook, Guy Pratt, et al.
Leukemia|June 20, 2020
Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma NetworkGordon Cook, Alessandra Larocca, Thierry Facon, et al.
Leukemia|July 25, 2022
Immune senescence in multiple myeloma-a role for mitochondrial dysfunction?Frances Seymour, Jonathan Carmichael, Claire Taylor, et al.
Critical Reviews in Oncology/Hematology|December 28, 2017
A question of class: Treatment options for patients with relapsed and/or refractory multiple myelomaGordon Cook, Sonja Zweegman, María-Victoria Mateos, et al.
Cancers|February 11, 2023
Development and Internal Validation of a Risk Prediction Model to Identify Myeloma Based on Routine Blood Tests: A Case-Control StudyLesley Smith, Jonathan Carmichael, Gordon Cook, et al.
BMC Medical Research Methodology|January 28, 2025
Artificial intelligence methods applied to longitudinal data from electronic health records for prediction of cancer: a scoping reviewVictoria Moglia, Owen Johnson, Gordon Cook, et al.
Cellular Immunology|June 9, 2015
Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapyGina B Scott, Clive Carter, Christopher Parrish, et al.
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Blood Reviews|April 30, 2013
Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM)Sylvia Feyler, Peter J Selby, Gordon Cook
British Journal of Haematology|November 15, 2020
Evolution or revolution in multiple myeloma therapy and the role of the UKGordon Cook, Curly T C M Morris
Palliative & Supportive Care|September 26, 2025
Advance care planning in haematological malignancies: A qualitative exploratory analysis of the facilitators and barriers to implementing advance care planning in practiceJenna Tate, Christopher Parrish, Anjum Khan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 12, 2016
Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in MyelomaBernard Maybury, Gordon Cook, Guy Pratt, et al.
Leukemia|June 20, 2020
Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma NetworkGordon Cook, Alessandra Larocca, Thierry Facon, et al.
Leukemia|July 25, 2022
Immune senescence in multiple myeloma-a role for mitochondrial dysfunction?Frances Seymour, Jonathan Carmichael, Claire Taylor, et al.
Critical Reviews in Oncology/Hematology|December 28, 2017
A question of class: Treatment options for patients with relapsed and/or refractory multiple myelomaGordon Cook, Sonja Zweegman, María-Victoria Mateos, et al.
Cancers|February 11, 2023
Development and Internal Validation of a Risk Prediction Model to Identify Myeloma Based on Routine Blood Tests: A Case-Control StudyLesley Smith, Jonathan Carmichael, Gordon Cook, et al.
BMC Medical Research Methodology|January 28, 2025
Artificial intelligence methods applied to longitudinal data from electronic health records for prediction of cancer: a scoping reviewVictoria Moglia, Owen Johnson, Gordon Cook, et al.
Cellular Immunology|June 9, 2015
Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapyGina B Scott, Clive Carter, Christopher Parrish, et al.
Pageof 18